In 2024, 135 drugs in India failed quality tests, leading to a seizure worth Rs 6.60 crores.

In November 2024, 135 drugs failed quality tests in India, identified as non-standard quality (NSQ) by both central and state laboratories. The Ministry of Health emphasized that the issue was with specific drug batches, not the entire market. Authorities seized drugs worth Rs 6.60 crores in a recent joint investigation in Kolkata. The publication of these lists aids in removing substandard drugs from the market.

2 months ago
9 Articles

Further Reading